Protocol Design Featured Articles
-
Biohaven Refines Epilepsy Trial Design With Patient-Centric Focus
1/17/2025
Medical director and clinical lead Jason T. Lerner, MD discusses Biohaven's patient-centric approach to its pediatric epilepsy clinical trials, from reducing visit frequency to offering virtual visits and more.
-
Bridging Continents For Clinical Development
1/16/2025
By leveraging Australia's ecosystem as a launchpad, organizations managing both early-stage and advanced development can enhance trial quality and position themselves for success.
-
Takeda Taps AI Partner To Improve Patient Selection, Clinical Assessments, And Treatment Pathways For IBD
1/10/2025
Takeda's Vijay Yajnik, MD, Ph.D. describes the company's partnership with an AI/ML vendor to improve endoscopic assessments in inflammatory bowel disease (IBD) research.
-
What Does It Mean To Be "Underserved"?
1/8/2025
Learn what makes someone "underserved," understand the importance of that person's participation in research, learn about the barriers to them doing so, and discover ways to improve their inclusion.
-
7 Most Talked About Factors To Transform Clinical Trials
1/3/2025
Ivanna Rosendal, global head of digitalization at Ascendis Pharma, shares the seven things guests on her podcast "Transformation in Trials" think will transform clinical trials.
-
How AI Will Transform Health Equity In Clinical Trials In 2025
12/23/2024
Click Therapeutics' CMO/CSO Shaheen Lakhan, MD, Ph.D., FAAN explains how the shift toward AI is the first step in addressing diversity in clinical trials.
-
What Future Laboratory Manuals Should Look Like
12/20/2024
In the final article of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair imagines what the perfect lab manual might look like — and how to make it a reality.
-
How Laboratory Manuals Fail Sites And Sponsors
12/19/2024
In part one of this series, FlexPoint Bio Founder and CEO Elena Sinclair describes the hazards of poorly designed (and followed) clinical trial lab manuals.
-
Lab Manual Gaps: Sabotaging Data One Sample At A Time
12/19/2024
In part two of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair discusses the criticality of sample and process quality.
-
BeiGene Details Its Approach To Expanding Oncology Trials Into Brazil
12/17/2024
In this second article, BeiGene's Lígia Campos details its journey to setting roots in Brazil, sharing its beginnings there and highlighting its approach to study start-up and patient recruitment and enrollment.